Literature DB >> 15888326

Ageing alters the production of nitric oxide and prostanoids after IL-1beta exposure in mesenteric resistance arteries.

Ana M Briones1, Mercedes Salaices, Elisabet Vila.   

Abstract

We aimed to analyse age influence on the production of inflammatory mediators from inducible isoforms of nitric oxide synthase (iNOS) and cyclooxygenase (COX-2) in rat mesenteric resistance arteries (MRA). The second and/or third branches of MRA from young (3-month-old) and old (22-month-old) male Sprague-Dawley rats were incubated in culture medium with or without interleukin-1ss (IL-1ss; 10 ng/ml, 14 h). IL-1ss did not modify endothelial NOS (eNOS) expression or endothelial cell distribution. However, IL-1ss increased nitrite production and iNOS expression in endothelial and smooth muscle cells more in arteries from young than from old rats. IL-1ss also increased PGI(2) levels and COX-2 expression in the three layers of the vascular wall. Ageing did not affect COX-2 expression but did increase TXA(2) and PGF(2alpha) levels. The maximum contraction to phenylephrine was increased in arteries from old rats after IL-1ss treatment. Inhibition of iNOS and COX-2 with 1400 W and NS398, respectively, abolished the differences in phenylephrine contraction. In conclusion, IL-1ss induced an inflammatory response in MRA with associated increases in iNOS and COX-2 expression. The lower increase in nitrite production from iNOS together with a greater contractile prostanoid production in the old rats would be responsible for the increase observed in their contraction to phenylephrine after IL-1 ss treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15888326     DOI: 10.1016/j.mad.2005.01.006

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  8 in total

1.  Western-style diet modulates contractile responses to phenylephrine differently in mesenteric arteries from senescence-accelerated prone (SAMP8) and resistant (SAMR1) mice.

Authors:  Francesc Jiménez-Altayó; Yara Onetti; Magda Heras; Ana P Dantas; Elisabet Vila
Journal:  Age (Dordr)       Date:  2012-07-10

2.  A role for cyclooxygenase in aging-related changes of beta-adrenoceptor-mediated relaxation in rat aortas.

Authors:  Khong Bee Kang; M A Sharmini Rajanayagam; Andrea van der Zypp; Henryk Majewski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-04-03       Impact factor: 3.000

3.  Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats.

Authors:  Y Alvarez; A M Briones; R Hernanz; J V Pérez-Girón; M J Alonso; M Salaices
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

4.  Differential effects of high consumption of fructose or glucose on mesenteric arterial function in female rats.

Authors:  Sonali Shaligram; Gemma Sangüesa; Farjana Akther; Marta Alegret; Juan C Laguna; Roshanak Rahimian
Journal:  J Nutr Biochem       Date:  2018-04-03       Impact factor: 6.048

Review 5.  The Future of IL-1 Targeting in Kidney Disease.

Authors:  Baris Afsar; Adrian Covic; Alberto Ortiz; Rengin Elsurer Afsar; Mehmet Kanbay
Journal:  Drugs       Date:  2018-07       Impact factor: 9.546

Review 6.  IL-1β and IL-18: inflammatory markers or mediators of hypertension?

Authors:  S M Krishnan; C G Sobey; E Latz; A Mansell; G R Drummond
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

7.  Valsartan decreases platelet activity and arterial thrombotic events in elderly patients with hypertension.

Authors:  Fang Wu; Hong-Yan Wang; Fan Cai; Ling-Jie Wang; Feng-Ru Zhang; Xiao-Nan Chen; Qian Yang; Meng-Hui Jiang; Xue-Feng Wang; Wei-Feng Shen
Journal:  Chin Med J (Engl)       Date:  2015-01-20       Impact factor: 2.628

8.  Age-related alterations in endothelial function of femoral artery in young SHR and WKY rats.

Authors:  Angelika Puzserova; Veronika Ilovska; Peter Balis; Peter Slezak; Iveta Bernatova
Journal:  Biomed Res Int       Date:  2014-03-20       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.